Hypoxia Regulation of the Lens
Hypoxia Regulation of the Lens
批准号:
10676923
负责人:
Marc Kantorow
金额:
$37.01万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-07-31
关键词:
AccelerationAdultBirthCataractCataract ExtractionCell CycleCellsCellular StructuresChickChick EmbryoComplexCrystalline LensCrystallinsDataDevelopmentEmbryoEmbryonic DevelopmentEndoplasmic ReticulumEnvironmentEpithelial CellsErythrocytesEventExhibitsGenesGenetic TranscriptionGolgi ApparatusHIF1A geneHRK geneHealthHyperoxiaHypoxiaKnockout MiceLens FiberLifeLinkMitochondriaMusOrganellesOxygenParkinPathologyPathway interactionsPhosphorylationPopulationPrevention therapyProteinsRegulationRegulatory PathwayReportingStructural ProteinStructureSurfaceTestingTissuesTranscriptional RegulationVascular blood supplyVisualcell growth regulationcyclin-dependent kinase inhibitor 1Bdesigndisabilityembryo cultureexperimental studyfiber cellinsightlensmouse modelnovelnovel therapeuticsoverexpressionprogramsprotein expressionresponsesuccesstranscription factor
中文摘要
项目摘要/摘要
这项申请寻求确定实现该结构所需的新机制和调控途径
和眼睛晶状体的功能。晶状体由表层的上皮细胞组成,在胚胎发育过程中,
在整个生命过程中,分化成晶状体纤维细胞,构成晶状体的核心和主体。要实现
其成熟的结构和透明的功能,新形成的晶状体纤维细胞必须完成一系列
以彻底消除细胞器和紧密结合为标志的细胞重塑方案
特殊晶状体蛋白的受控表达。晶状体纤维细胞重塑程序的中断导致
晶状体结构缺陷与白内障的形成使这些机制的识别和调控
通路对于促进我们对成熟晶状体形成和病理的理解是至关重要的。我们最近做了
发现红细胞中线粒体降解的关键调节因子,称为BNIP3L,是
胚胎晶状体中线粒体、内质网和高尔基体的特异性消除
晶状体无细胞器区的形成。这些研究确定了消除非
胚胎晶状体纤维细胞重塑中的核细胞器及其建立的一种全新的
BNIP3L在内质网和高尔基体降解中的作用建议进行的实验
在AIM1中,现在试图通过建立在消除中对BNIP3L的新要求来推进这些发现
这些细胞器在成人晶状体纤维细胞重塑过程中的作用,并试图揭示其机制,
它们依赖于BNIP3L的消除所需的调控途径和辅助蛋白。缺少鲜血
供应镜片包含从镜片表面到镜片核心的逐渐减小的氧气梯度。实验目的
2旨在检验晶状体低氧是晶状体结构的新要求这一新假说,以及
低氧依赖控制晶状体纤维细胞细胞器消除的透明度和
关键基因的调控,包括BNIP3L、细胞周期退出蛋白p27和结构蛋白CP49,
通过激活低氧反应的主要调节因子,低氧诱导的转录因子
HIF1a。这些目标的成功实现将对我们的理解产生重大的长期影响
导致眼晶状体结构成熟和透明功能的细胞重塑途径。这个
这一结果也有望促进对细胞重塑途径的识别
更复杂的组织的形成和功能。
英文摘要
Project Summary/Abstract
This application seeks to identify novel mechanisms and regulatory pathways required to achieve the structure
and function of the eye lens. The lens consists of a surface layer of epithelial cells that during embryogenesis,
and throughout life, differentiate into lens fiber cells that make up the core and bulk of the lens. To achieve
their mature structure and transparent function, newly-formed lens fiber cells must complete a sequential
program of cellular remodeling hallmarked by the complete elimination of cellular organelles and the tightly
controlled expression of specialized lens proteins. Disruption of the lens fiber cell remodeling program causes
defective lens structure and cataract formation so that identification of these mechanisms and regulatory
pathways is critical for advancing our understanding of mature lens formation and pathology. We have recently
discovered that a key regulator of mitochondrial degradation in erythrocytes, called BNIP3L, is required for the
specific elimination of mitochondria, endoplasmic reticulum and Golgi apparatus in the embryonic lens during
formation of the lens organelle-free zone. These studies identify the first requirement for the elimination of non-
nuclear organelles during the remodeling of embryonic lens fiber cells and they establish an entirely novel
function for BNIP3L in the degradation of endoplasmic reticulum and Golgi apparatus. Experiments proposed
in AIM1 now seek to advance these findings by establishing a novel requirement for BNIP3L in the elimination
of these organelles during the remodeling of adult lens fiber cells and they seek to reveal the mechanisms,
regulatory pathways and auxiliary proteins required for their BNIP3L-dependent elimination. Lacking a blood
supply the lens contains a diminishing oxygen gradient from the lens surface to the lens core. Experiments AIM
2 are designed to test the novel hypothesis that lens hypoxia is a novel requirement for lens structure and
transparency through the hypoxia-dependent control of organelle-elimination in lens fiber cells and the
regulation of critical genes including BNIP3L, the cell-cycle exit protein p27 and the structural protein CP49,
through activation of the master regulator of the hypoxic response, hypoxia-inducible transcription factor
HIF1a. The successful completion of these AIMs will have a significant long-term impact on our understanding
of the cellular remodeling pathways leading the mature structure and transparent function of the eye lens. The
results are also expected to advance the identification of cellular remodeling pathways required for the
formation and function of more complex tissues.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.exer.2020.108129
发表时间:
2020-09
期刊:
Experimental eye research
影响因子:
3.4
作者:
[Brennan L, Disatham J, Kantorow M]
通讯作者:
Kantorow M
DOI:
10.1186/s13072-022-00440-z
发表时间:
2022-03-05
期刊:
Epigenetics & chromatin
影响因子:
3.9
作者:
[Disatham J, Brennan L, Jiao X, Ma Z, Hejtmancik JF, Kantorow M]
通讯作者:
Kantorow M
DOI:
10.1186/s12864-021-07795-9
发表时间:
2021-07-03
期刊:
BMC genomics
影响因子:
4.4
作者:
[Disatham J, Brennan L, Chauss D, Kantorow J, Afzali B, Kantorow M]
通讯作者:
Kantorow M
Hypoxia Regulation of the Lens
-
批准号:10456991
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2019
-
负责人:Marc Kantorow
-
依托单位:
Hypoxia Regulation of the Lens
-
批准号:10246917
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2019
-
负责人:Marc Kantorow
-
依托单位:
Repurposing classical death pathways for signaling roles in lens differentiation
-
批准号:9054227
-
项目类别:
-
资助金额:$55.42万
-
财政年份:2015
-
负责人:Marc Kantorow
-
依托单位:
Regulatory role of PI3K signaling pathways in lens differentiation and function
-
批准号:10361557
-
项目类别:
-
资助金额:$50.28万
-
财政年份:2015
-
负责人:Marc Kantorow
-
依托单位:
Repurposing classical death pathways for signaling roles in lens differentiation
-
批准号:9187024
-
项目类别:
-
资助金额:$54.21万
-
财政年份:2015
-
负责人:Marc Kantorow
-
依托单位:
Regulatory role of PI3K signaling pathways in lens differentiation and function
-
批准号:9917206
-
项目类别:
-
资助金额:$53.23万
-
财政年份:2015
-
负责人:Marc Kantorow
-
依托单位:
Regulatory role of PI3K signaling pathways in lens differentiation and function
-
批准号:10580706
-
项目类别:
-
资助金额:$51.83万
-
财政年份:2015
-
负责人:Marc Kantorow
-
依托单位:
Molecular Analysis of Microdissected Human Lenses
-
批准号:8020927
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Molecular Analysis of Microdissected Cataractous Human Lenses
-
批准号:7159319
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
MOLECULAR ANALY MICRODISSECTED CATARACTOUS HUMAN LENSES
-
批准号:6384885
-
项目类别:
-
资助金额:$19.06万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
MOLECULAR ANALY MICRODISSECTED CATARACTOUS HUMAN LENSES
-
批准号:6179812
-
项目类别:
-
资助金额:$18.51万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
MOLECULAR ANALY MICRODISSECTED CATARACTOUS HUMAN LENSES
-
批准号:6665364
-
项目类别:
-
资助金额:$20.22万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Mol. Anal. of Microdissected Cataractous Human Lenses
-
批准号:6874065
-
项目类别:
-
资助金额:$31.01万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Molecular Analysis of Microdissected Human Lenses
-
批准号:7885098
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
MOLECULAR ANALY MICRODISSECTED CATARACTOUS HUMAN LENSES
-
批准号:6525149
-
项目类别:
-
资助金额:$20.61万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Mol. Anal. of Microdissected Cataractous Human Lenses
-
批准号:7879806
-
项目类别:
-
资助金额:$18.98万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
MOLECULAR ANALYSIS OF MICRODISSECTED CATARACTOUS HUMAN L
-
批准号:2829954
-
项目类别:
-
资助金额:$19.15万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Molecular Analysis of Microdissected Human Lenses
-
批准号:8213504
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Mol. Anal. of Microdissected Cataractous Human Lenses
-
批准号:6986107
-
项目类别:
-
资助金额:$30.55万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
Molecular Analysis of Microdissected Cataractous Human Lenses
-
批准号:7541339
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1999
-
负责人:Marc Kantorow
-
依托单位:
海外基金